UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis

American journal of ophthalmology, 2018-10, Vol.194, p.7-15

2018

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis

Clinical ophthalmology (Auckland, N.Z.), 2019-03, Vol.13, p.535-544

2019

Link zum Volltext

Verfügbarkeit prüfen

Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations

Health and quality of life outcomes, 2019-10, Vol.17 (1), p.163-163, Article 163

2019

Link zum Volltext

Verfügbarkeit prüfen

Dissociable Neural Patterns of Facial Identity across Changes in Viewpoint

Journal of cognitive neuroscience, 2010-07, Vol.22 (7), p.1570-1582

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Model to Predict Ocular Itching Outcomes at 24 Hours Post-Treatment with Olopatadine (0.77% or 0.2%)

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB257-AB257

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis

American journal of ophthalmology, 2019-09, Vol.205, p.197-197

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea, 2015-10, Vol.34 (10), p.1245

2015

Link zum Volltext

Verfügbarkeit prüfen

Reply

American journal of ophthalmology, 2019-01, Vol.197, p.184-185

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.1703-1713

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety Of a New Olopatadine Hydrochloride, 0.77% Ophthalmic Formulation In Patients With Allergic Conjunctivitis Using The Conjunctival Allergen Challenge (CAC) Model (NCT01479374)

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB277-AB277

2014

Link zum Volltext

Verfügbarkeit prüfen

An other-race effect for face recognition algorithms

ACM transactions on applied perception, 2011-01, Vol.8 (2), p.1-11

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase 2, randomized, controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for the treatment of adenoviral conjunctivitis

Journal of AAPOS, 2018-08, Vol.22 (4), p.e50-e50

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.669-681

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply

American journal of ophthalmology, 2019-01, Vol.197, p.184

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply

American journal of ophthalmology, 2019-01, Vol.197, p.184-185

2019

Link zum Volltext

Verfügbarkeit prüfen

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.1089-1097

2017

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticles for the Treatment of Uveal Melanoma

Uveal Melanoma, p.135-149

Link zum Volltext

Verfügbarkeit prüfen

Humans versus algorithms: Comparisons from the Face Recognition Vendor Test 2006

2008 8th IEEE International Conference on Automatic Face & Gesture Recognition, 2008, p.1-6

2008

Link zum Volltext
IEEE_Xplore

Named Entity Recognition and Aspect based Sentiment Analysis

International journal of computer applications, 2019-09, Vol.178 (46), p.18-23

2019

Link zum Volltext

Verfügbarkeit prüfen

Intelligent tutoring system for Database Normalization

2016 International Conference on Computing Communication Control and automation (ICCUBEA), 2016, p.1-6

2016

Link zum Volltext

Verfügbarkeit prüfen

Review of knowledge representation techniques for Intelligent Tutoring System

2016 3rd International Conference on Computing for Sustainable Global Development (INDIACom), 2016, p.2508-2512

2016

Link zum Volltext

Verfügbarkeit prüfen

Detecting Offensive Text on Facebook Using Natural Language Processing and Machine Learning

Advanced Computing Technologies and Applications, 2020, p.645-656

2020

Link zum Volltext

Verfügbarkeit prüfen

User-Based Personalized Text Summarizer

Advanced Computing Technologies and Applications, 2020, p.663-677

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis

A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis

Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations

Dissociable Neural Patterns of Facial Identity across Changes in Viewpoint

Pharmacodynamic Model to Predict Ocular Itching Outcomes at 24 Hours Post-Treatment with Olopatadine (0.77% or 0.2%)

Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Reply

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

Efficacy and Safety Of a New Olopatadine Hydrochloride, 0.77% Ophthalmic Formulation In Patients With Allergic Conjunctivitis Using The Conjunctival Allergen Challenge (CAC) Model (NCT01479374)

An other-race effect for face recognition algorithms

A phase 2, randomized, controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for the treatment of adenoviral conjunctivitis

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Reply

Reply

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

Nanoparticles for the Treatment of Uveal Melanoma

Humans versus algorithms: Comparisons from the Face Recognition Vendor Test 2006

Named Entity Recognition and Aspect based Sentiment Analysis

Intelligent tutoring system for Database Normalization

Review of knowledge representation techniques for Intelligent Tutoring System

Detecting Offensive Text on Facebook Using Natural Language Processing and Machine Learning

User-Based Personalized Text Summarizer

Suchergebnisse filtern